Lixte Biotechnology Holdings, Inc. · NASDAQ:LIXT
Sawyer Jason David received 40,000 Lixte Biotechnology Holdings, Inc. shares as an award (Form 4)
Traded Jul 1, 2026 · Filed Jul 2, 2026
On Jul 1, 2026, Sawyer Jason David (Director) received 40,000 Lixte Biotechnology Holdings, Inc. shares as an award, leaving 65,000 shares. Filed Jul 2, 2026 (Form 4).
- Awarded
- 40,000 shares
- Holding after
- 65,000 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | Award | 40,000 | 65,000 | Direct |
Source
Related
- Lixte Biotechnology Holdings, Inc.
- Sawyer Jason David
- Lixte Biotechnology Holdings, Inc. shareholders
- Form 4 · Sawyer Jason David · Apr 17, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Stazzone Peter · Jul 2, 2026
- Form 4 · Pursglove Geordan Garrett · Jul 2, 2026
- Form 4 · Primus Guy Warren · Jul 2, 2026
- Form 4 · Holloway Michael Andrew · Jul 2, 2026